Under the terms of the employment letter agreement, Mr. Hanson will receive a base salary of $70,666.67 per month, which is subject to applicable withholding. Additionally, he is eligible for an annual cash performance bonus opportunity for 2026, with a target bonus set at 120% of his annualized base salary, prorated for the duration of his service as Interim CEO. Furthermore, Mr. Hanson will receive an award of restricted stock units (RSUs) with a grant date value of no less than $2,027,075, which will vest based on specific performance goals and timelines.
The company has indicated that Mr. Hanson will continue to serve as Chairman of the Board during his tenure as Interim CEO. The compensation package reflects the company’s commitment to retaining experienced leadership during this transitional period. The changes in leadership and compensation are expected to provide stability and continuity in the company’s operations, which is crucial for maintaining investor confidence.
This leadership change is seen as a strategic move to ensure that the company remains on track with its operational goals while navigating the challenges posed by the current market environment. The board of directors will continue to evaluate the situation and make necessary adjustments to the leadership structure as needed.
Overall, the appointment of Mr. Hanson is viewed positively, as it brings experienced leadership to the forefront during a critical time for American Healthcare REIT, Inc. Investors will be closely monitoring the company’s performance under this new leadership and the impact of the revised compensation structure on its operational execution and strategic outlook.
